Founder Lodge | Exchange with founders who raised capital, hired employees & got cashflow.

Certified by Founder Lodge

Ascenta Capital

Venture Capital and Private Equity Principals,

United States - ND

INVESTOR

1 Disclosed Funding Rounds $200,000,000
7 Participating Investments

Ascenta Capital invests in biotechs.

Company	Date	Round	Raised
Alpha-9 Oncology	October, 24 ,2024	Series C	$175,000,000
ADARx Pharmaceuticals Inc.	August, 10 ,2023	Series C	$200,000,000
Tubulis GmbH	October, 16 ,2025	Series C	$359,197,300
Iambic Therapeutics	October, 06 ,2023	Series B	$100,000,000
Odyssey Therapeutics	December, 06 ,2023	Series C	$101,000,000
Alpha-9 Oncology	October, 24 ,2024	Series C	$175,000,000
Tubulis GmbH	October, 16 ,2025	Series C	$359,197,300